ARDELYX, INC. Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
ARDELYX, INC. (ARDX) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $4.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2019-11-06
- 2019-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $4.00K.
- 2019-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $16.00K.
- 2019-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $12.00K.
- 2018-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $1.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2019-09-30 | $4.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $16.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $12.00K 10-Q · filed 2019-05-07 |
| 2018-06-30 | $1.00K 10-Q · filed 2018-08-07 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-14 |
| 2017-09-30 | $3.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $5.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $7.00K 10-K · filed 2018-03-14 |
| 2016-09-30 | $9.00K 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |